Deleveraging and Strong Liquidity
Redeemed remaining $150M of 2027 senior unsecured notes; total net debt down $119M year-over-year to $639M; trailing-12-month leverage ratio improved to 2.7x from 4.6x; quarter-end liquidity of $379M (cash $74M + revolver ~ $305M).
Adjusted EBITDA and Margin Expansion
Q2 adjusted EBITDA $86M, up 3.3% versus prior year Q2; adjusted EBITDA margin improved to 19.1% from 17.0% year-over-year; first-half adjusted EBITDA $152M, up 32% versus prior year H1, with H1 margin rising to 17.9% from 14.5%.
Plant Nutrition Turnaround — Ogden Driving Performance
Plant Nutrition revenue $67M, up ~15.5% year-over-year (from $58M); Plant Nutrition adjusted EBITDA $17M, up 202% year-over-year and margin improved to 25.2% from 9.6%; Ogden facility delivering strong cost performance and higher utilization.
Improved Per-Ton Economics in Salt
Salt operating earnings per ton increased to $15.85, up 21% versus $13.10 in prior year Q2, reflecting price realization despite higher distribution/product costs and lower volumes.
Portfolio Simplification Completed
Sale of Wynyard SOP operation completed during the quarter, strengthening cash position and allowing focus on core Ogden Plant Nutrition asset.
Cost and SG&A Discipline
Company reported lower SG&A year-over-year and emphasized focus on cost control and working capital management; interest expense guidance lowered to $62M–$67M reflecting debt paydown.
Maintained Full-Year Adjusted EBITDA Midpoint
Updated full-year adjusted EBITDA guidance range of $212M–$236M with midpoint $224M essentially unchanged; Plant Nutrition full-year outlook raised (now $43M–$47M midpoint $45M).